ABSTRACT: Chondrogenesis of mesenchymal stem cells (MSCs) is induced in culture conditions that have been associated with oxidative stress, although the extent to which the oxidative environment affects differentiation and extracellular matrix (ECM) accumulation is not known. The objectives of this study were to evaluate the oxidative environment during MSCs chondrogenesis in conventional serumfree medium, and the effect of serum-supplementation on intracellular reactive oxygen species (ROS) and chondrogenesis. Young adult equine MSCs were seeded into agarose and cultured in chondrogenic medium, with or without 5% fetal bovine serum (FBS), for up to 15 days. Samples were evaluated for intracellular ROS, the antioxidant glutathione, ECM and gene expression measures of chondrogenesis, and carbonylation as an indicator of oxidative damage. Intracellular ROS increased with time in culture, and was lower in medium supplemented with FBS. Glutathione decreased $12-fold during early chondrogenesis (p < 0.0001), and was not affected by FBS (p ¼ 0.25). After 15 days of culture, FBS supplementation increased hydroxyproline accumulation $80% (p ¼ 0.0002); otherwise, measures of chondrogenesis were largely unaffected. Protein carbonylation in chondrogenic MSCs cultures was not significantly different between serum-free and FBS cultures (p ¼ 0.72). Supplementation with adult equine serum increased hydroxyproline accumulation by 45% over serum-free culture (p ¼ 0.0006). In conclusion, this study characterized changes in the oxidative environment during MSC chondrogenesis, and suggested that lowering ROS may be an effective approach to increase collagen accumulation. ß
The ability of bone marrow mesenchymal stem cells (MSCs) to undergo chondrogenesis has fostered enthusiasm for tissue engineering approaches to resurface damaged or diseased articular cartilage. Mesenchymal stem cells are isolated and expanded in an uncommitted state, and require exposure to chondrogenic factors to induce differentiation and subsequent secretion of cartilage-like extracellular matrix (ECM). 1 To ensure that MSCs receive such cues, tissue engineering strategies have been designed to provide controlled exposure to chondrogenic factors during pre-implantation culture [2] [3] [4] [5] or as a component of the cell-seeded graft. [6] [7] [8] [9] Current strategies for inducing MSCs chondrogenesis are largely focused on growth factors that stimulate differentiation. However, it has been postulated that additional measures to support the growth and maintenance of repair tissue will increase the likelihood of success. 10 One such measure may be modulation of the oxidative environment. Oxidative stress is generated when cells are unable to neutralize excessive reactive oxygen species (ROS), or are incapable of recycling oxidized biomolecules. The potential for the development of oxidative stress with chondrogenesis was indicated by a chondrogenic cell line (ATDC5), which experienced an increase in ROS with time in culture. 11 For MSCs, the most commonly used culture medium for inducing chondrogenesis includes transforming growth factor beta (TGF-b), 1 which has been reported to decrease endogenous concentrations of the antioxidant glutathione and increase intracellular ROS. 12 Furthermore, conventional chondrogenic medium does not contain serum. Serum withdrawal is a cell culture technique used to eliminate unknowns associated with serum, synchronize cell cycle, or induce stress, autophagy, or apoptosis. 13 In particular, serum starvation can increase the production of ROS, [14] [15] [16] which may occur due to nutrient deprivation. 15 While these data indicate that ROS are generally supportive of MSCs chondrogenesis, the extent to which excess ROS is produced during in vitro chondrogenesis, resulting in oxidative stress, has not been considered.
In chondrocyte cultures, high levels of ROS have been associated reduced synthesis of proteoglycans. 17, 18 In mature fibrocartilage, elevated ROS in vivo coincided with increased oxidative damage in the ECM, which was associated with altered mechanical properties and increased susceptibility to degradation. 19 These data suggest that for chondrogenic MSCs, oxidative stress may lead to suboptimal volume and/or quality of the repair tissue. Therefore, the first objective of this study was to characterize the oxidative environment during chondrogenesis in conventional serum-free medium. Next, we evaluated the potential of serum to reduce intracellular ROS, and the concomitant effect on chondrogenesis and oxidative damage. Experiments were conducted using young adult equine MSCs encapsulated in agarose hydrogel, a scaffold that supports robust chondrogenesis of equine MSCs. Initial experiments evaluated intracellular ROS and endogenous concentrations of glutathione over time in serum-free chondrogenic culture. Next, we characterized the ability of fetal bovine serum (FBS) supplementation to reduce intracellular ROS, and the effect on cell viability, ECM accumulation, and extracellular oxidative damage. Finally, the potential to use adult serum as a chondrogenic medium supplement was evaluated by comparing viability and ECM accumulation to serum-free or FBS-supplemented medium.
METHODS

MSC Isolation and Expansion
Bone marrow was aspirated from the iliac crest of four 2-5-year-old mixed breed horses euthanized for reasons unrelated to this study. Colony-forming cultures were established in low glucose Dulbecco's modified Eagle medium (Thermo Fisher Scientific, Waltham, MA) supplemented with 10% FBS (GE Healthcare Life Sciences, Chicago, IL) that was heat-inactivated (56˚C for 30 min), 10 mM HEPES (Thermo Fisher Scientific), and antibiotic/antimycotic solution (100 U/ml penicillin, 100 mg/ml streptomycin, and 0.25 mg/ml Gibco Amphotericin B) (Thermo Fisher Scientific). MSCs were collected after 6-7 days of culture, and were reseeded at 2 Â 10 3 cells/cm 2 in minimal essential medium alpha (Thermo Fisher Scientific), 10% FBS, 10 mM HEPES, antibiotic/antimycotic solution, and 2 ng/ml fibroblast growth factor-basic (Peprotech, Rocky Hill, NJ). 20 The cultures were incubated for 4 days, and then passaged a second time prior to seeding in chondrogenic culture. Cultures were incubated at 37˚C in ambient air plus 5% carbon dioxide. All basal media contained sodium bicarbonate (2.2 g/L) to maintain physiological pH. Previously, equine MSCs obtained using this protocol were capable of trilineage differentiation, [20] [21] [22] and express a pattern of cell membrane cluster of differentiation molecules consistent with the MSC phenotype.
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Agarose Encapsulation and Chondrogenic Culture Culture-expanded MSCs were encapsulated in 1.5% (w/v) agarose gel at 12 Â 10 6 cells/ml, as previously described. 20 Chondrogenic medium 1 consisted of high-glucose Dulbecco's modified Eagle medium (Thermo Fisher Scientific) supplement with 6.25 mg/ml insulin, 6.25 mg/ml transferrin, 6.25 ng/ml selenious acid, 1.25 mg/ml bovine serum albumin, and 5.35 mg/ml linoleic acid (ITSþ Premix, BD Biosciences, Bedford, MA, abbreviated in the manuscript as "ITS"), 37.5 mg/ml ascorbate-2-phosphate (Wako Chemicals, Richmond, VA), 100 nM dexamethasone (Sigma-Aldrich, Saint Louis, MO), and 5 ng/ml recombinant human TGF-b1 (Peprotech). For certain experiments chondrogenic medium was supplemented with heat-inactivated 5% FBS, with or without ITS. Allogeneic equine serum was obtained from a 5-year-old horse. Blood was collected without anticoagulant, stored at 4˚C for 24 h, and then centrifuged at 1,000g for 10 min. Five percent adult equine serum was evaluated in chondrogenic medium containing ITS. Chondrogenic cultures were incubated at 37˚C in ambient air plus 5% carbon dioxide for up to 15 days, with medium changed every third day.
Quantification of Extracellular Matrix Accumulation and DNA Content
MSCs-seeded agarose samples were digested in proteinase K (Sigma-Aldrich) in Tris-HCl solution at 60˚C overnight.
From the digest, total accumulated sulfated glycosaminoglycan (GAG) and hydroxyproline were quantified by dimethylmethylene blue 23 and dimethylamino benzaldehyde dye 24 binding assays, respectively. DNA was quantified using the Hoechst dye assay as previously described. 25 Extracellular matrix accumulation was normalized to the wet weight or DNA content of each sample.
Cell Viability MSC-seeded agarose samples were evaluated for viability using the CellTiter-Blue 1 (CTB) assay (Promega, Madison, WI) per the manufacturer's instructions. Sample were incubated in medium containing CTB at 37˚C for 1 h and 15 min, and then the reaction was stopped by adding 3% SDS and incubating at room temperature for 15 min. Aliquots of medium were analyzed for CTB absorbance at 490 (excitation) and 529 nm (emission) wavelengths on a microplate reader. Data were reported as CTB absorbance normalized to the wet weight of the sample.
Qualitative ROS Staining
MSC-seeded agarose samples were fluorescent labeled with CellROX 1 green reagent (Thermo Fisher Scientific) in chondrogenic culture medium at 37˚C for 45 min. The samples were washed, and intracellular fluorescence was imaged using an Olympus IX83 Inverted Microscope. Images were collected using an exposure time of 1 s.
Quantification of ROS
MSCs were seeded in 48-well plates at 25 Â 10 3 cells/cm 2 , and incubated overnight in expansion medium. The medium was changed to serum-free chondrogenic medium or chondrogenic medium plus 5% FBS, and cultured for an additional 24 h. The cells were labeled in serum-free chondrogenic medium containing 10 mM 2 0 ,7 0 -dichlorofluorescein diacetate (DCFDA; Sigma-Aldrich) for 30 min at 37˚C. Cultures were washed three times with phosphate buffered saline, and the cells were lysed using a solution of 50 mM Tris, 150 mM NaCl, and 1% Triton X-100. Cell lysates were analyzed at 490 nm (excitation) and 529 nm (emission) wavelengths on a microplate reader. Background absorbance, obtained from lysate from cells incubated without DCFDA during the labeling period, was subtracted from labeled cultures. Data were reported as DCFDA absorbance normalized to the total protein content of the cell lysates determined with a Pierce BCA protein assay kit (Thermo Scientific, Rockford, IL).
Glutathione Content
MSC-seeded agarose samples were analyzed for total glutathione or oxidized glutathione (GSSG) using a commercial kit (GSH/GSSG-Glo TM Assay [Promega]) according to the manufacturer's instructions. Data were normalized to the wet weight of the samples. Total glutathione and GSSG were used to calculate for ratio of reduced/oxidized glutathione (GSH/GSSG ratio).
Protein Carbonyl Content
MSC-seeded agarose samples were pulverized, and then digested for 6 h at 37˚C with 0.5 U/ml of chondroitinase ABC (Sigma-Aldrich). Soluble proteins were extracted using 1 M NaCl according to the methods of Scharf et al. 19 As a control, articular cartilage samples from 2-to 5-year-old horses were incubated in 40 U/ml collagenase for 2 h and 30 min at 37˚C, subjected to nine freeze-thaw cycles, 19 and then processed as OXIDATIVE ENVIRONMENT AND CHONDROGENESIS performed for MSCs-seeded agarose. To compare the ECM extraction efficiency of 1 M NaCl, extract from MSCs cultured in chondrogenic medium containing ITS and 5% FBS or articular cartilage were evaluated for hydroxyproline content. In addition, samples that were not treated with chondroitinase ABC were subjected to NaCl extraction, which was then evaluated for GAG content. NaCl extraction solutions were diluted sixfold with water, and carbonylation was quantified using a commercial kit , cooled in liquid nitrogen, and pulverized. Five hundred microliters of TRIzol 1 was first added to the pulverized samples, followed by chloroform at a ratio of 1:5 to the TRIzol 1 . Samples were centrifuged at 12,000g at 4˚C for 15 min, and RNA was extracted from the aqueous phase using the RNeasy Mini Kit (Qiagen, Valencia, CA) according to the manufacturer's instructions with oncolumn genomic DNase (Qiagen). mRNA was reverse transcribed into cDNA using superscript 1 III first-strand synthesis system for RT-PCR (Thermo Fisher Scientific), and evaluated for aggrecan, types I, II, and X collagen, and matrix metalloproteinase 13 (MMP 13) using the Biorad CFX96 TM RealTime PCR Detection System (Biorad, Hercules, CA). Relative gene expression levels were determined by semi-quantitative real time PCR using primers and SYBR Green (Table 1) . Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as housekeeping gene.
Immunohistochemical and Histological Staining
MSC-seeded agarose samples were fixed in 10% formalin for 48 h, paraffin-embedded, sectioned, and mounted on slides. Sections were de-paraffinized and rehydrated prior to staining.
Type II Collagen Immunohistochemical Staining
Samples were incubated with proteinase K (Sigma-Aldrich) solution at 37˚C for 15 min. Sections were exposed to mouse anti-collagen type II IgG primary antibody using undiluted supernatant (Hybridoma Bank, Iowa City, IA), followed by donkey anti-mouse IgG secondary antibody conjugated with peroxidase at a 1:500 dilution (Jackson Immunoresearch, West Grove, PA). Antibody detection was performed using VECTOR 1 NovaRED TM (Vector laboratories, Burlingame, CA). Additional sections were incubated with normal mouse serum at equal concentration to that of the primary antibody as a negative control. Equine cartilage was analyzed in parallel as a positive control.
Toluidine Blue
Sections were stained with 0.04% Toluidine blue solution (Electron Microscopy Sciences, Fort Washington, PA).
Statistical Analysis
Each experiment was conducted using MSCs from four horses. Data were evaluated for normality using the Shapiro-Wilk test. Data that showed a normal distribution were analyzed for analysis of variance with mixed model using animal as a random effect. Pairwise comparisons of medium conditions were analyzed using least squares means with Tukey-Kramer adjustment. For glutathione content, medium condition and time were considered main effects, and pairwise comparisons of main effect and their interactions were performed. Data showing a non-normal distribution were analyzed using Wilcoxon matched-pairs signed rank test. p-values less than 0.05 were considered statistically significant. Statistical tests for normal distribution and nonparametric test were performed using GraphPad Prism 7, and correlation and parametric tests were performed using SAS 9.3 software. Data are presented as mean AE SEM.
RESULTS
Throughout the manuscript and in figures serum-free chondrogenic medium is denoted as "ITS," chondrogenic medium plus 5% FBS as "ITS/FBS," and chondrogenic medium containing 5% FBS but without ITS as "FBS."
CellRox Staining in ITS Medium
CellRox staining was evaluated after 1 or 6 days of culture. Intracellular fluorescence in samples that were not labeled with CellRox was not grossly detectable (data not shown). Intracellular ROS staining was faint after 1 day of culture (Fig. 1, representative images of all samples). By day 6, intracellular ROS staining had increased compared to day 1.
Glutathione Content in ITS or ITS/FBS Medium
Total glutathione and GSSG were evaluated after 1 or 6 days of culture (Fig. 2) . Individual pairwise comparisons are not reported as the interactions between medium and time were not significant (p ¼ 0.25). Independent of medium conditions, total glutathione decreased $12-fold between days 1 and 6 of culture (p < 0.0001). On day 1, the ratio of GSH/GSSG in ITS/ FBS medium was 50% higher than ITS culture (p ¼ 0.001). GSSG was below the detection limit of the assay on day 6. Monolayer cultures were analyzed for intracellular ROS using DCFDA after 1 day of incubation in chondrogenic media. The level of intracellular ROS in ITS cultures (0.62 AE 0.10 DCFDA absorbance/mg protein) was 2.6-fold higher than ITS/FBS cultures (0.24 AE 0.03 DCFDA absorbance/mg protein) (p < 0.001, data not shown).
CellRox staining was evaluated immediately after encapsulating MSCs in agarose, and then after 3, 9, or 15 days of chondrogenic culture (Fig. 3) . On day 0, intracellular staining was faint. In ITS medium intracellular staining increased over time, in a manner that resembled the short timecourse presented in Figure 1 . In ITS/FBS medium, intracellular staining increased slightly with time in culture, and to a much lower extent than in ITS culture.
Cell Viability in ITS, ITS/FBS, or FBS Medium
Cell viability was evaluated after 7 and 15 days of culture. Each timepoint was statistically analyzed separately due to the absence of a control that would account for potential variability that may result from running the assay on different days. On day 7, the viable cell density in ITS (394 AE 35 CTB absorbance/ mg wet weight) was not significant different than ITS/ FBS (467 AE 100 CTB absorbance/mg wet weight, p ¼ 0.63, data not shown). On day 15, the viable cell density in ITS (302 AE 19 CTB absorbance/mg wet weight) was not significant different than ITS/FBS (348 AE 3 CTB absorbance/mg wet weight). For FBS samples, the viable cell density was 7.8-fold (50 AE 18 CTB absorbance/mg wet weight; p ¼ 0.01) and 3.7-fold (82 AE 27 CTB absorbance/mg wet weight; p ¼ 0.0004) lower than ITS cultures on day 7 and 15, respectively.
Extracellular Matrix Accumulation in ITS, ITS/FBS, or FBS Medium
ECM accumulation was evaluated after 15 days of culture. When normalized to wet weight, mean GAG and hydroxyproline accumulation in ITS cultures was 1.8 and 0.22 mg/mg wet weight, respectively (Fig. 4A) . In ITS/FBS cultures, GAG accumulation was not significantly different than ITS (p ¼ 0.99), while hydroxyproline was 83% higher than ITS cultures (p ¼ 0.0002). In samples cultured in FBS medium GAG and hydroxyproline accumulation were relatively low, approximately equivalent to 2% and 20% of that in ITS cultures, respectively (p ¼ 0.0016 and p ¼ 0.0001, respectively). Glycosaminoglycan and hydroxyproline accumulation in FBS samples were significantly lower than ITS/FBS cultures (p ¼ 0.0001 and p < 0.0001, respectively). DNA was quantified from digests that were analyzed for ECM. For each sample DNA normalized to wet weight was plotted against previous measures of cell viability (data not show). Correlation analysis resulted in a correlation coefficient of 0.92, which indicated that DNA is reflective of the viable cell content. Normalizing ECM accumulation to DNA did not change the outcome of the statistical analysis, with ECM accumulation in FBS cultures approximately 25% of ITS or ITS/FBS (Fig. 4B) .
Protein Carbonylation in ITS or ITS/FBS Medium
Samples were analyzed after 15 days of culture. For MSC-seeded agarose cultured in ITS/FBS medium, the GAG and hydroxyproline content in NaCl extracts were 0.175 AE 0.027 and 0.0081 AE 0.0007 mg/mg total protein, respectively. For adult cartilage, the GAG and hydroxyproline content in NaCl extracts were 0.226 AE 0.027 and 0.0064 AE 0.0009 mg/mg total protein, respectively. These data indicate that the concentration of the major components of cartilage ECM were comparable between chondrogenic culture and native cartilage. In chondrogenic MSCs cultures, the carbonyl content was not significantly different between ITS 
Histological Staining in ITS or ITS/FBS Medium
Samples were analyzed after 15 days of culture. Toluidine blue (Fig. 6A ) and type II collagen staining (Fig. 6B ) was present in all samples. Relatively intense staining was localized to pericellular spaces. Interterritorial staining for type II collagen appeared to be higher for ITS/FBS cultures.
Gene Expression in ITS or ITS/FBS Medium
Gene expression was analyzed after 15 days of culture. Types I (p ¼ 0.12) and X collagen (p ¼ 0.18), and MMP13 (p ¼ 0.36) expression were not significantly different between ITS and ITS/FBS cultures (data not shown). Aggrecan and Type II collagen expression in samples cultured in ITS/FBS medium was 3.1-fold (p ¼ 0.04) and 2.8-fold (p ¼ 0.01) lower than ITS samples, respectively (data not shown).
Extracellular Matrix Accumulation in Medium Supplemented With Adult Equine Serum
Extracellular matrix accumulation was evaluated after 15 days of culture. Cell viability and ECM accumulation in chondrogenic medium supplemented with ITS and allogeneic adult equine serum were compared to ITS and ITS/FBS culture. Viability was not significantly different among culture conditions (p ¼ 0.7, data not shown). GAG accumulation was not significantly different among culture conditions (p ¼ 0.34, Fig. 7 ). Hydroxyproline accumulation in adult serum cultures was 45% higher than ITS (p ¼ 0.0006), and 15% lower (p ¼ 0.014) than ITS/FBS (Fig. 7) .
DISCUSSION
Serum-free medium has been widely used to induce MSCs chondrogenesis in vitro, resulting in robust secretion of GAG-and type II collagen-rich ECM. In this study, such chondrogenesis was associated with early increases of intracellular ROS that persisted over 15 days of culture, which is consistent with temporal patterns reported for chondrogenesis of ATDC5 cells. 11 In addition, increasing ROS may 
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TANGTRONGSUP AND KISIDAY explain previous reports of increased prostaglandin E2 (PGE2) secretion with progression of chondrogenesis, 26, 27 given that a relationship between ROS and PGE2 has been demonstrated in chondrocytes. 28 The reduction in glutathione ( Fig. 2A) during early MSCs chondrogenesis suggests that increases in intracellular ROS are at least in part due to downregulation of endogenous antioxidants, which has been previously reported for MSCs chondrogenesis and superoxide dismutase. 29 Moderate levels of ROS can act as important secondary messengers that influence stem cell survival, migration, and differentiation. 30 For example, ROS-generating NADPH oxidase that supports chondrogenesis 11 has been associated with the PI3K pathway, 31 which has also been shown to support chondrogenesis. 32, 33 Therefore, elevated levels of ROS may play an important role in MSCs chondrogenesis.
Given that the striking increase in intracellular ROS with chondrogenesis suggests the potential for oxidative stress, we investigated the effect of decreasing ROS by supplementing the medium with FBS. In this study, FBS proved to be an effective antioxidant based on the increased ratio of reducedto-oxidized glutathione during early chondrogenesis (Fig. 2B) , and lowering of intracellular ROS relative to serum-free culture (Fig. 3) . The biological significance of the reduction in ROS with FBS here is supported by experiments using different cell types in which two-to fivefold changes in ROS with serum-starvation were associated with induction of apoptosis 14, 16, 34 or autophagy. 35 For chondrogenesis, the most significant effect of FBS was a $80% increase in collagen accumulation without a concomitant increase in proteoglycan content (Fig. 4) , which is consistent with reports that ROS can differentially affect the synthesis of collagen and proteoglycans. 36 Otherwise, the reduction in ROS with FBS did not greatly affect most chondrogenic assays. Differences in intracellular ROS did not translate to extracellular oxidative damage (Fig. 5) , although intracellular ROS may not predict extracellular oxidative damage as redox modulation can differ between intra-and extracellular spaces. 37 Taken together, these data indicate that MSCs are largely effective in managing the oxidative environment associated with chondrogenesis.
An important aspect of our experimental design was that FBS was added to chondrogenic medium containing ITS. This approach differs from early exploration of serum as a stand-alone basal supplement for chondrogenic medium, which for bone marrow MSCs failed to support stable formation of pellet cultures.
1 For synovium-derived MSCs seeded in alginate, serum-supplementation alone resulted in moderately lower type II collagen and aggrecan gene expression related to serum-free, ITS supplemented medium. 38 These results were consistent with low cell viability and ECM accumulation in FBS medium here.
Taken together it appears that ITS, and perhaps specifically insulin, 39, 40 plays a critical role in supporting MSCs chondrogenesis. Fetal bovine serum has been investigated in combination with ITS for synovium-derived MSCs in pellet culture, where it moderately decreased ECM accumulation, and lowered type II collagen gene expression and immunohistochemical staining. 41, 42 These results may differ from the current study based on the different tissue source for MSCs, or the use of pellet instead of hydrogel cultures.
MSC chondrogenesis may be particular vulnerable to extracellular oxidative stress as differentiation has been reported to coincide with decreases in superoxide dismutase gene and protein expression, 29 which has been shown to be downregulated by TGF-b. 43 This potential is supported by the finding that protein carbonylation in chondrogenic MSCs hydrogels was significantly higher than age-matched articular OXIDATIVE ENVIRONMENT AND CHONDROGENESIS 511 cartilage (Fig. 5) . Elevated oxidative damage has been associated with pathological changes in mature tissue such as intervertebral disc fibrocartilage with aging, 19 or heart valves with disease. 44 However, additional information is needed to determine whether the extent to which oxidative damage is increased in chondrogenic MSCs is sufficient to compromise cartilage repair.
For the culture of MSCs for clinical applications, the use of FBS has raised concerns about an immune response induced by xenogenic materials. Therefore, while increasing collagen accumulation with FBS supplementation of chondrogenic medium is compelling, the use of species-matched or autologous serum in place of FBS would alleviate a major concern. For chondrocytes, adult serum has been reported to be equivalent or superior to FBS for expansion, redifferentiation, and ECM accumulation in three dimensional culture. 45, 46 Here, collagen accumulation more closely resembled bovine cartilage explant cultures in which proteoglycan synthesis increased among serumfree, adult serum, and FBS cultures. 47 While adult serum did not maximize collagen accumulation, the 45% increase over serum-free culture (Fig. 7) may be considered advantageous compared to the further modest gains supported by FBS. Additional studies are needed to more rigorously characterize the effect of adult serum on chondrogenesis, including potential variability among individuals. In addition, it is possible that concentrations of serum that are lower than the 5% used in this study may be equally or more effective in supporting chondrogenesis. 46, 48, 49 In conclusion, this study identified temporal changes in the oxidative environment during MSCs chondrogenesis, and the potential benefit of adding antioxidants to existing methods of inducing differentiation. Furthermore, the evaluation of serum as an antioxidant here may be particularly important for tissue engineering strategies that seek to induce chondrogenesis in vivo as serum is a component of synovial fluid. For these results, there are several limitations to consider. Given that serum-starvation may have a broad effect across cell functions, 13 the use of antioxidants may more precisely correlate the influence of ROS on chondrogenesis. We evaluated young adult equine MSCs based on the use of 2-5-year-old horses for animal models of cartilage resurfacing. However, in humans the need for cartilage healing is prevalent through mid-adulthood, and older cells may be less capable of tolerating the oxidative environment during chondrogenesis due to a loss of antioxidant capacity with aging. [50] [51] [52] Chondrogenic cultures were maintained in ambient air, which is particularly relevant to oxidative stress as ambient oxygen is hyperoxic for bone marrow MSCs, 53 and may promote the generation of ROS and oxidative damage as demonstrated in murine monolayer culture. 54 Reduced oxygen has been shown to enhance ECM accumulation in chondrogenic MSCs cultures, 55, 56 and based on the current study the positive effect of low oxygen may be in part due to reduced levels of ROS. In this case, it is possible that adding serum in low oxygen chondrogenic culture would lower the production of ROS below a critical level for supporting chondrogenesis, as observed for antioxidant treatment of ATDC5 cultures.
11 While extracellular oxidative damage may compromise the repair potential of chondrogenic MSCs, a more comprehensive analysis is needed to better understand the degree to which components of the ECM are affected, and the effect of such oxidative modifications on the maturation of neo-cartilage in vivo. Such studies would better define the potential impact of modulating ROS to improve the use of MSCs to heal cartilage defects. 
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